Reconfirmed outlook and early progress in debt profile improvement
19/11/23 -"Bastide’s “more international, more specialised” strategy has again been proven efficient in the Q1 trading update, while the positives have been considerably erased by the continuing weak Homecare ..."
Pages
48
Language
English
Published on
19/11/23
You may also be interested by these reports :
23/06/26
There’s an interesting paradox at the heart of Sartorius Stedim Biotech’s (SSB; ADD; France) investment case. Since our last push in February 2025, ...
03/06/26
Despite a reduction in our target price, as discussed in the EPS section, our positive recommendation on Qiagen remains unchanged. This optimism is ...
29/05/26
Elekta’s Q4 results revealed an adjusted EBIT exceeding expectations, although sales fell short. The company offered qualitative guidance for ...
26/05/26
Piling up assets is no strategy